By Denny Jacob
23andMe shares dived 43% in premarket trading Monday after disclosing that it initiated voluntary Chapter 11 bankruptcy proceedings in court to facilitate a sale process.
Shares were trading around $1.02. The stock is down 80% over the last year.
The DNA-testing company said it's seeking a court authorization to sell substantially all of its assets through the bankruptcy proceedings. It intends to use the proceedings to resolve all outstanding legal liabilities stemming from a prior cyberattack.
23andMe earlier in the year signaled such a move was possible. The company in January said it was exploring strategic alternatives, including a sale of some or all of its assets, in the face of a cash crunch.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
March 24, 2025 06:32 ET (10:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。